盘龙药业：南五味子开发成果丰硕，为农民增收致富开辟新路径

Core Viewpoint - The development of rural characteristic industries is crucial for promoting comprehensive rural revitalization, with Panlong Pharmaceutical actively participating in this initiative through the cultivation of South Schisandra [1][2]. Group 1: Company Initiatives - Panlong Pharmaceutical has signed an agreement with the local government to establish a South Schisandra planting and wild nurturing base, which is significant for consolidating poverty alleviation results and promoting rural revitalization [1][3]. - The company has completed over 100,000 acres of wild nurturing for South Schisandra and has facilitated the planting of over 2,000 acres, creating a substantial scale effect [5][6]. - Panlong Pharmaceutical has developed a series of innovative products, including oral slices and functional foods, which are expected to generate over 20 million yuan in annual revenue [5][6]. Group 2: Industry Context - South Schisandra, known for its medicinal, edible, and ornamental properties, has significant market development potential, with the region of Zhashui being a primary production area due to its abundant wild resources and high-quality output [2][3]. - The local industry has seen a rise in demand for South Schisandra in both food and pharmaceutical sectors, leading to an increase in the area cultivated and nurtured [4][5]. - The company aims to address key issues in the South Schisandra industry, such as the lack of quality seeds and outdated production techniques, to enhance quality and efficiency [4][6].